The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,284
Sort by:
IVF Devices and Consumables Market Report by Product (Instruments, Accessories and Disposables, Reagents and Media), Technology (Fresh Embryo IVF, Frozen Embryo IVF, Donor Egg IVF), End User (Fertility Clinics, Hospitals, Surgical Centers, Clinical Research Institutes), and Region 2026-2034
US$ 3,999.00
The global IVF devices and consumables market size reached USD 3.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 9.3 Billion by 2034, exhibiting a growth rate (CAGR) of...
April 2026
138 pages
Neutropenia Treatment Market Report by Treatment (Colony-Stimulating Factors, Antibiotics, Antifungals, Antivirals), Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2026-2034
US$ 3,999.00
The global neutropenia treatment market size reached USD 16.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 25.4 Billion by 2034, exhibiting a growth rate (CAGR) of 4.5...
April 2026
141 pages
Non-Alcoholic Steatohepatitis (NASH) Market by Drug Type (Vitamin E and Pioglitazone, Ocaliva, Elafibranor, Selonsertib, Cenicriviroc, and Others), Disease Cause (Hypertension, Heart Disease, High Blood Lipid, Type 2 Diabetes, Obesity), Sales Channel (Hospital Pharmacy, Online Providers, Retail Pharmacy), End User (Hospitals, Clinics, Homecare Settings), and Region 2026-2034
US$ 3,999.00
The global non-alcoholic steatohepatitis (NASH) market size reached USD 2.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 14.9 Billion by 2034, exhibiting a growth rate...
April 2026
141 pages
Peptic Ulcer Drugs Market Size by Product Type (Proton Pump Inhibitors, Potassium-Competitive Acid Blocker (P-CAB), Antacids, H2-Antagonists, Antibiotics, Ulcer protective), Ulcer Type (Gastric Ulcer, Duodenal Ulcer, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2026-2034
US$ 3,999.00
The global peptic ulcer drugs market size reached USD 5.0 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 6.3 Billion by 2034, exhibiting a growth rate (CAGR) of 2.41% du...
April 2026
143 pages
Anti-Tuberculosis Therapeutics Market Report by Disease Type (Active TB, Latent TB, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Specialty Clinics, Homecare, and Others), and Region 2026-2034
US$ 3,999.00
The global anti-tuberculosis therapeutics market size reached USD 1,615.1 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 2,615.3 Million by 2034, exhibiting a growth rat...
April 2026
143 pages
Antifibrinolytic Drugs Market Report by Indication (Gynecology, Hereditary Angioedema, Fibrinolytic Response Testing, Surgeries, and Others), Form (Oral, Injectable), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Trauma Centers, and Others), and Region 2026-2034
US$ 3,999.00
The global antifibrinolytic drugs market size reached USD 18.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 25.1 Billion by 2034, exhibiting a growth rate (CAGR) of 3....
April 2026
135 pages
Hemoglobinopathies Market Report by Type (Thalassemia, Sickle Cell Disease, and Others), Treatment (Blood Transfusion, Stem-cell Transplantation, Analgesics, Antibiotics, ACE Inhibitors, Hydroxyurea, and Others), Test Type (Red Blood Cell (RBC) Count, Genetic Testing, High Performance Liquid Chromatography (HPLC), Hemoglobin Isoelectric Focusing (Hb IEF), Hemoglobin Electrophoresis (Hb ELP), Hemoglobin Solubility Test), End User (Hospitals and Clinics, Diagnostics Laboratories, and Others), and Region 2026-2034
US$ 3,999.00
The global hemoglobinopathies market size reached USD 11.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 23.3 Billion by 2034, exhibiting a growth rate (CAGR) of 7.52%...
April 2026
147 pages
Large Volume Parenteral (LVP) Market Report by Type (Soft Bag LVP, Plastic Bottle LVP, Glass Bottle LVP), Volume (100 ML - 250 ML, 250 ML - 500 ML, 500 ML - 1000 ML, 1000 ML - 2000 ML, 2000 ML and More), Application (Therapeutic Injections, Fluid Balance Injections, Nutritious Injections), End Users (Hospitals, Clinics, and Others), and Region 2026-2034
US$ 3,999.00
The global large volume parenteral (LVP) market size reached USD 10.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 17.4 Billion by 2034, exhibiting a growth rate (CAGR...
April 2026
141 pages
Non-PVC IV Bags Market Report by Material (Ethylene Vinyl Acetate, Copolyester-ether, Polypropylene, and Others), Product (Multi Chamber, Single Chamber), Content (Frozen Mixture, Liquid Mixture), Application (Chemotherapy, Targeted Drug Delivery, Glucose Injection, Sodium Chloride Solution, Electrolyte Injection, Nutrient Injection, and Others), End User (Hospitals, Clinics, Emergency Service Centers, Ambulatory Surgical Centers, and Others), and Region 2026-2034
US$ 3,999.00
The global non-PVC IV bags market size reached USD 2.0 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.4 Billion by 2034, exhibiting a growth rate (CAGR) of 5.56% durin...
April 2026
146 pages
Ulcerative Colitis Market Report by Type (Mild UC, Moderate UC, Severe UC), Disease Type (Ulcerative Proctitis, Proctosigmoiditis, Left-sided Colitis, Pancolitis or Universal Colitis, Fulminant Colitis), Molecule Type (Small Molecules, Biologics), Drug Type (Anti-Inflammatory Drugs, Anti-TNF Biologics, Immunosuppressant, Calcineurin Inhibitors, and Others), Route of Administration (Oral, Injectable), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Store, and Others), and Region 2026-2034
US$ 3,999.00
The global ulcerative colitis market size reached USD 8.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 13.0 Billion by 2034, exhibiting a growth rate (CAGR) of 4.63% d...
April 2026
150 pages
Erythropoietin Drugs Market Size, Share, Trends and Forecast by Drug Class, Product Type, Application, End User, and Region, 2026-2034
US$ 3,999.00
The global erythropoietin drugs market size was valued at USD 12,097.4 Million in 2025. Looking forward, IMARC Group estimates the market to reach USD 18,184.2 Million by 2034, exhibiting a CAGR of 4....
April 2026
138 pages
Genitourinary Drugs Market Report by Indication (Prostate Cancer, Ovarian Cancer, Bladder Cancer, Cervical Cancer, Renal Cancer, Erectile Dysfunction, Urinary Tract Infections, Urinary Incontinence and Overactive Bladder, Sexually Transmitted Diseases, Interstitial Cystitis, Hematuria, Benign Prostatic Hyperplasia), Product (Urological, Hormonal Therapy, Gynecological, Anti-infectives, and Others), and Region 2026-2034
US$ 3,999.00
The global genitourinary drugs market size reached USD 34.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 40.2 Billion by 2034, exhibiting a growth rate (CAGR) of 1.68%...
April 2026
150 pages
Hirsutism Market Report by Therapy Type (Procedures, Medication), Products (Hair Removal Equipment, Topical Hair Removal Products, and Others), End User (Hospitals, Clinics, and Others), and Region 2026-2034
US$ 3,999.00
The global hirsutism market size reached USD 3.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 5.7 Billion by 2034, exhibiting a growth rate (CAGR) of 5.73% during 2026...
April 2026
149 pages
Hospital Infection Therapeutics Market Report by Drug Type (Anti-bacterial Drugs, Anti-fungal Drugs, Anti-viral Drugs, and Others), Indication (Blood Stream Infections, Urinary Tract Infections, Surgical Site Infections, Pneumonia, and Others), and Region 2026-2034
US$ 3,999.00
The global hospital infection therapeutics market size reached USD 13.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 19.9 Billion by 2034, exhibiting a growth rate (CA...
April 2026
142 pages
India Saline Solution Market Size, Share, Trends and Forecast by Product Type, Packaging Type, End-Use, Application, and Region, 2026-2034
US$ 3,999.00
The India saline solution market size reached USD 736.7 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,458.3 Million by 2034, exhibiting a growth rate (CAGR) of 7.65%...
April 2026
140 pages
Gastroparesis Drugs Market Report by Disease Type (Diabetic Gastroparesis, Idiopathic Gastroparesis, Post-surgical Gastroparesis, and Others), Drug Class (Prokinetic Agents, Antiemetic Agents, Botulinum Toxin Injections), Distribution Channel (Hospitals and Clinics, Pharmacies, Online Stores), and Region 2026-2034
US$ 3,999.00
The global gastroparesis drugs market size reached USD 7.0 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 10.0 Billion by 2034, exhibiting a growth rate (CAGR) of 3.90%...
April 2026
140 pages
Psoriatic Arthritis Treatment Market Report by Drug Type (NSAIDs (Nonsteroidal Anti-Inflammatory drugs), DMARDs (Disease-Modifying Anti-Rheumatic Drugs), Biologics, and Others), Type (Prescription, OTC), Route of Administration (Injectable, Oral, Topical), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2026-2034
US$ 3,999.00
The global psoriatic arthritis treatment market size reached USD 11.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 24.1 Billion by 2034, exhibiting a growth rate (CAGR...
April 2026
136 pages
Superdisintegrants Market Report by Product (Croscarmellose Sodium, Crospovidone, Sodium Starch Glycolate, Ion Exchange Resin, Modified Cellulose, and Others), Type (Natural Superdisintegrant, Synthetic Superdisintegrant, and Others), Dosage Form (Tablets and Capsules, Mouth-Dissolving Films), Therapeutic Areas (Gastrointestinal, Cardiovascular, Neurology, Oncology, Hematology, and Others), and Region 2026-2034
US$ 3,999.00
The global superdisintegrants market size reached USD 469.5 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 787.2 Million by 2034, exhibiting a growth rate (CAGR) of 5.73...
April 2026
139 pages
Analgesics Market Size, Share, Trends, and Forecast by Type, Drug Class, Route of Administration, Pain Type, Application, and Region, 2026-2034
US$ 3,999.00
The global analgesics market size was valued at USD 58.4 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 81.2 Billion by 2034, exhibiting a CAGR of 3.73% during 2026-20...
April 2026
141 pages
MRSA Drugs Market Size by MRSA Type (Hospital-Acquired (HA-MRSA), Community-Acquired (CA-MRSA)), Drug Class (Lipopeptides, Oxazolidinones, Cephalosporin, Tetracycline, Folate Antagonist, and Others), Disease Indication (Skin Infections, Bone and Joint Infections, Bacteremia, Animal Infections), Route of Administration (Oral Administration, Parenteral Administration), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2026-2034
US$ 3,999.00
The global MRSA drugs market size reached USD 4.0 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 5.2 Billion by 2034, exhibiting a growth rate (CAGR) of 2.89% during 202...
April 2026
145 pages
Pompe Disease Treatment Market Size by Treatment (Enzyme Replacement Therapy (ERT), Substrate Reduction Therapy (SRT), Chaperone-Advanced Replacement Therapy (CART), and Others), Route of Administration (Oral, Intravenous, and Others), Distribution Channel (Hospital and Clinics Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), Indication Type (Infantile-Onset Pompe Disease (IOPD), Classic Infantile Form, Non-Classic Infantile Form, Late-Onset Pompe Disease (LOPD), and Others), and Region 2026-2034
US$ 3,999.00
The global Pompe disease treatment market size reached USD 1.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 1.4 Billion by 2034, exhibiting a growth rate (CAGR) of 2.3...
April 2026
139 pages
Herpes Simplex Virus Treatment Market Size, Share, Trends and Forecast by Type, Drug Type, Route of Administration, Distribution Channel, and Region, 2026-2034
US$ 3,999.00
The global herpes simplex virus treatment market size was valued at USD 2.8 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 4.2 Billion by 2034, exhibiting a CAGR of 4....
April 2026
141 pages
Disease-Modifying Therapies (DMT) Market - 2025-2033
US$ 2,999.00
The Disease-Modifying Therapies (DMT) Market was valued at US$ 165.88 Billion in 2025 and is anticipated to reach US$ 281.88 Billion by 2033, at a CAGR of 0.0643 from 2026 to 2032. The report delivers...
March 2026
186 pages
NASH/MASH Treatment Market - 2025-2033
US$ 2,999.00
The NASH/MASH Treatment Market was valued at US$ 8.13 billion in 2025 and is anticipated to reach US$ 33.02 billion by 2033, at a CAGR of 0.1755 from 2026 to 2032. The report delivers in-depth insight...
March 2026
210 pages
Primary Sclerosing Cholangitis Market - 2025-2033
US$ 2,999.00
The Primary Sclerosing Cholangitis Market was valued at US$ 385.67 million in 2025 and is anticipated to reach US$ 987.26 million by 2033, at a CAGR of 0.1221 from 2026 to 2032. The report delivers in...
March 2026
243 pages
Colistin Market Size and Forecast (2021 - 2034), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Formulation [Injectables (IV or IM), Oral, Topical Formulations, and Inhalation Solutions], Indication [Human Health (Bloodstream Infections (BSI) and Sepsis Lower, Respiratory Tract Infections (LRTI), Urinary Tract Infections (UTIs), Central Nervous System Infections, Skin Infections, Cystic Fibrosis, Tracheobronchitis or VAP, Gastrointestinal Infections, and Bowel Decontamination) and Animal Health], Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Channel, and Other Distribution Channels), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
US$ 4,450.00
The Colistin market size is expected to grow from US$ 337.00 million in 2025 to US$ 510.94 million by 2034; it is projected to register a CAGR of 4.8% during 2026–2034. The increased multidrug-resista...
March 2026
346 pages
Pharmaceutical Excipients Market Size and Forecast (2021 - 2034), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Bioresorbable Polymers and Lipids and Liposome Based Formulation, Oleochemicals, Sugars, Cellulose, Starches, Petrochemicals, Plant Proteins Polyols and Cyclodextrins, Inorganic Chemicals, and Other Types), Clinical Indication (Cancer, Metabolic, Infectious Disease, Dental, Ophthalmic, Cardiovascular, and Other Clinical Indications), Functionality (Coloring Agents and Coating Agents, Sweetner and Flavoring Agents, Suspending and Viscosity Agents, Preservative and Controlled Release, Antioxidant and Oil, Tablet Filler and Diluent, Binder and Compression and Granulating Agents, Emulsifiers, Surfactants, and Other Functionality), Application (Oral, Injectable, Topical, and Other Application), End User (Pharma Industries, Biopharma Industries, Animal Health, and Other End User), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
US$ 4,450.00
The pharmaceutical excipients market size is expected to grow from US$ 10.03 billion in 2025 to US$ 17.60 billion by 2034; it is projected to register a CAGR of 6.5% during 2026–2034. The surging dema...
March 2026
701 pages
Adapalene Market Size, Share & Trends Analysis Report By Formulation (Gels, Creams, Lotions), By Drug Composition (Adapalene Monotherapy), By Prescription, By Indication, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global adapalene market size was estimated at USD 605.5 million in 2025 and is projected to reach USD 789.5 million by 2033, growing at a CAGR of 3.9% from 2026 to 2033. The market is experiencing...
March 2026
108 pages
Anti-Inflammatory Drugs Market - 2025-2033
US$ 2,999.00
The Anti-Inflammatory Drugs Market was valued at US$ 114.58 billion in 2025 and is anticipated to reach US$ 156.92 billion by 2033, at a CAGR of 0.0364 from 2026 to 2032. The report delivers in-depth...
March 2026
217 pages
IgA Nephropathy Treatment Market - 2025-2033
US$ 2,999.00
The IgA Nephropathy Treatment Market was valued at US$ 525.43 million in 2025 and is anticipated to reach US$ 2674.01 million by 2033, at a CAGR of 0.2241 from 2026 to 2032. The report delivers in-dep...
March 2026
217 pages
Anti-Obesity Drugs Market - 2022-2030
US$ 2,999.00
The Anti-Obesity Drugs Market was valued at US$ 2.5 billion in 2022 and is anticipated to reach US$ 43.7 billion by 2030, at a CAGR of 0.455 from 2026 to 2032. The report delivers in-depth insights in...
March 2026
217 pages
Global Inflammatory Bowel Disease Market - 2024-2033
US$ 2,999.00
The Global Inflammatory Bowel Disease Market was valued at US$ 22.48 Billion in 2024 and is anticipated to reach US$ 36.27 Billion by 2033, at a CAGR of 0.055 from 2026 to 2032. The report delivers in...
March 2026
200 pages
Prescription Drugs Market - 2024-2032
US$ 2,999.00
The Prescription Drugs Market was valued at US$ 1240.33 billion in 2024 and is anticipated to reach US$ 2151.63 billion by 2032, at a CAGR of 0.071 from 2026 to 2032. The report delivers in-depth insi...
March 2026
220 pages
Contrast Media Market By Type (lodinated Contrast Media), Form (Liquid, Powder), Modality (X-ray, MRI, Ultrasound), Route of Administration (Oral, Rectal), Indication (Cancer, Neurological, GI, Musculoskeletal Disorders) & Region - Global Forecast to 2031
US$ 4,950.00
... in the contrast media/contrast agents market Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various contrast media/contrast agents across regions Market Diversification: Exhaustive ...
March 2026
267 pages
Parenteral Nutrition Market Size, Share & Trends Analysis Report By Nutrient Type (Carbohydrates, Parenteral Lipid Emulsion, Vitamins & Minerals), By Stage Type (Adult, Pediatric), By Indication, By Sales Channel (Online, Retail), By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global parenteral nutrition market size is expected to reach USD 8.26 billion by 2026, according to a new report by Grand ... patient benefits North America led the market in terms of revenue and accounted for 41.73% of the overall share in 2018. Presence of high research expenditure ...
March 2026
190 pages
Boric Acid Suppository Market Size, Share & Trends Analysis Report By Drug Type, (Standard Boric Acid Suppositories, Combination Formulations), By Application (Vaginal Infection Treatment), By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global boric acid suppository market size was estimated at USD 352.13 million in 2025 and is projected to reach USD 485.94 million by 2033, growing at a CAGR of 4.17% from 2026 to 2033. The market...
March 2026
150 pages
Gastrointestinal Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (Branded, Generics), By Drug Class (Laxatives, Anti-emetics), By Route Of Administration, By Application, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global gastrointestinal therapeutics market size is expected to reach USD 65.1 billion by 2025, according to a new report ... forecast period. Growing geriatric population prone to gastrointestinal indications is one of the key factors anticipated to contribute to market growth. According to a report by WHO, ...
March 2026
140 pages
Hypothalamic Obesity Treatment Market 2026
US$ 2,999.00
The Hypothalamic Obesity Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includin...
March 2026
200 pages
